PI3K pathway activation can also cause chemotherapy resistance in breast cancer cells by increasing the outflow of chemotherapeutic drugs through adenosine triphosphate (ATP)-binding cassette transporter and the association between AKT phosphorylation and increased cell migration and apoptosis [32,33]. Here, AKT1 is linked to breast cancer.